Clinical Trials Browser

Phase 2/3 × Carcinoma, Squamous Cell × Gemcitabine × Clear all

NCT01631357 2019-11-05

CIK

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell